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Patients with multiple sclerosis (MS) have an increased systemic vascular resistance
(SVR) response during the metaboreflex. It has been hypothesized that this is the
consequence of a sedentary lifestyle secondary to MS. The purpose of this study
was to discover whether a 6-month training program could reverse this hemodynamic
dysregulation. Patients were randomly assigned to one of the following two groups:
the intervention group (MSIT, n = 11), who followed an adapted training program;
and the control group (MSCTL, n = 10), who continued with their sedentary lifestyle.
Cardiovascular response during the metaboreflex was evaluated using the post-exercise
muscle ischemia (PEMI) method and during a control exercise recovery (CER) test. The
difference in hemodynamic variables such as stroke volume (SV), cardiac output (CO),
and SVR between the PEMI and the CER tests was calculated to assess themetaboreflex
response. Moreover, physical capacity was measured during a cardiopulmonary test
till exhaustion. All tests were repeated after 3 and 6 months (T3 and T6, respectively)
from the beginning of the study. The main result was that the MSIT group substantially
improved parameters related to physical capacity (+5.31± 5.12 ml·min−1/kg in maximal
oxygen uptake at T6) in comparison with the MSCTL group (−0.97 ± 4.89 ml·min−1/kg
at T6; group effect: p = 0.0004). However, none of the hemodynamic variables changed
in response to the metaboreflex activation. It was concluded that a 6-month period
of adapted physical training was unable to reverse the hemodynamic dys-regulation in
response to metaboreflex activation in these patients.
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INTRODUCTION
Exercise training is a well-established intervention to improve physical capacity in many types
of diseases. Beneficial effects have been reported in heart failure, chronic ischemic heart disease,
hypertension, diabetes, and other metabolic conditions. For example, training has been found
capable to improve physical capacity and quality of life in heart failure, to reduce blood pressure,
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to increase survival after infarction, and to increase insulin
sensitivity (Pedersen and Saltin, 2015). Recently, improvements
in symptoms and quality of life have also been demonstrated in
neurological pathologies. Among others, Multiple Sclerosis (MS)
has been found to be positively affected by physical exercise,
as peak oxygen uptake and oxygen pulse were found improved
after periods of training, thereby suggesting an increase exercise
tolerance in these patients. Moreover, training may induce a
positive effect on MS fatigue (Rampello et al., 2007; Dalgas
et al., 2008; Andreasen et al., 2011; Pedersen and Saltin, 2015).
However, data on the effect of supervised physical training on
hemodynamic regulation during exercise in MS patients are
scarce.
One of the key symptoms in MS is exertion fatigue, which is
reported by 50–60% of these patients as their most disturbing
problem (Tartaglia et al., 2005; Mollaoug˘lu and U˝stu˝n, 2009;
Andreasen et al., 2011). Several reasons might be responsible
for this phenomenon. Of these, cardiovascular dysregulation
during exercise has been observed in some investigations dealing
with MS (Ng et al., 2000; Sanya et al., 2005). Some individuals
with MS may have impairment of the autonomically-mediated
blood pressure response during isometric exercise, and this
phenomenon has been suggested to be related to symptomatic
fatigue (Ng et al., 2000).
In healthy subjects, hemodynamic regulation during exercise
is achieved by the integration of signals arising from mechano-
and metabo-receptors within the working muscle and central
command activation, which together concur in increasing
sympathetic activity (O’Leary et al., 2004; Amann et al., 2011;
Nobrega et al., 2014). The increased sympathetic activity is
modulated in turn by the baroreflex activation, which dampens
any excessive increment in sympathetic tone (Crisafulli et al.,
2015). Several clues suggest that MS can influence these
cardiovascular reflexes, thereby impairing the hemodynamic
response during exertion (Ng et al., 2000; Flackenecher et al.,
2001; Sanya et al., 2005; Marongiu et al., 2013). For instance,
it was found impaired baroreflex control of the HR rate
in MS patients, as well as impairment of the sympathetic-
mediated baroreflex control of blood vessels, which together
can explain the high incidence of orthostatic dizziness in these
patients (Sanya et al., 2005). Moreover, our group has recently
demonstrated that MS patients had an altered hemodynamic
response to metaboreflex activation (Marongiu et al., 2015). This
response resembled that showed by patients with cardiovascular
and metabolic disease, where the target blood pressure is
reached mainly by means of vasoconstriction (Piepoli et al.,
2008; Delaney et al., 2010; Dipla et al., 2010; Choi et al.,
2013; Crisafulli et al., 2013; Milia et al., 2015b). In healthy
subjects, during the metaboreflex, a cardiac output-mediated
mechanism is primarily responsible for the normal increase in
mean blood pressure (MBP; Crisafulli et al., 2003, 2008; Delaney
et al., 2010; Roberto et al., 2012; Spranger et al., 2013). In the
investigation by Marongiu et al. (2015), it was hypothesized
that physical deconditioning was responsible for the exaggerated
vasoconstriction and the increase in SVR found in MS during
the metaboreflex. This hypothesis is supported by previous
findings suggesting that deconditioning may play a key role in
the impaired exercise tolerance of people with MS (Rampello
et al., 2007). Moreover, others have reported a shift in fiber type
composition from type I fibers to a greater proportion of type II
fibers in MS patients as a consequence of deconditioning (Dalgas
et al., 2008). This occurrence may potentially have an impact on
the metaboreflex activation as metabolites production is related
to fiber type, with type II producing higher amounts of end-
products than type I. It is then reasonable to assume that a shift
from type I to type II in themuscle fiber composition would result
in a more robust metaboreflex activity.
Therefore, we wondered whether a physical training program,
along with its effects on physical capacity, could also counteract
the reported cardiovascular dysregulation to the metaboreflex
in these patients. To address this question, two groups of
patients with MS were studied: one underwent a program of
adapted physical activity (APA) and the other did not. The
cardiovascular response to the muscle metaboreflex was then
assessed at baseline, at three, at 6 months from the beginning
of the study. To detect whether or not improvements in the
capacity to exercise were paralleled by improvements in the
hemodynamic response to the metaboreflex activation, indices of
physical capacity were also evaluated.
MATERIALS AND METHODS
Study Population
Twenty-five MS patients were selected from the database of the
Multiple Sclerosis center of the Department of Public Health,
Clinical and Molecular Medicine, of the University of Cagliari,
Italy. Inclusion criteria were: (1) clinically established diagnosis
of MS, defined according to the criteria proposed by Poser
et al. (1983); (2) age between 18 and 65 years; (3) no relapse
or deterioration during the 4 weeks prior to tests; (4) absence
of other associated medical conditions that would interfere
with the autonomic function and/or chronic cardiopulmonary
diseases; (5) absence of involvement in any training program.
Patients taking β-blockers, sympatho mimetics, anticholinergics,
Amantadin, and/or tricyclic antidepressants were excluded.
Complete neurological and medical history were obtained from
each patient. Neurological examination was conducted and
disability was evaluated according to the Expanded Disability
Status scale (EDSS), which yielded an average value of 3.5 ±
0.7 (range 1.4–4.5; Kurtkze, 1983). At the time of the study,
patients were on treatment with disease modifying drugs mainly,
interferon-β, glatiramer acetate, fingolimod, or natalizumab.
A computer program was used to randomly assign patients to
one of the following two groups:
Intervention MS group [MSIT group; a cohort of 13 patients
(6 women and 7 men)]. The MSIT underwent a 6-month
supervised training program (STP) including both aerobic and
strength training. The 6-month period was chosen because
it was reported that in MS patients substantial improvement
in physical capacity can be obtained with short periods (2–
6 months) of supervised physical activity (Rampello et al.,
2007; Dalgas et al., 2008). Briefly, patients participated in
three training sessions per week. Each session lasted 1 h and
consisted in a 10-min warm-up on an electromagnetically braked
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cycle ergometer (Forma Bike 5000, Technogym, Forlì, Italy) at
30% of the maximum workload previously calculated during a
cardiopulmonary test (CPT). Patients then performed stretching
exercises of their upper and lower limbs and trunk muscles.
This was followed by 20 min of aerobic training obtained by
cycling at a work rate corresponding to 50% of their maximum.
This workload was progressively increased every week up to
80% of maximum work rate, and adjusted every 3 months,
taking into consideration results obtained from the CPT, which
was repeated every 3 months. After this period of aerobic
training, patients were instructed to perform gait exercises, such
as ambulation combining advancement of one lower limb with
raising of the opposite upper limb and tandem gait. Then,
the period of strength training began and involved muscles
of the upper and lower limb and trunk. In terms of sets,
repetitions and load, patients started with 1 set of 8 repetitions
for each muscle group at a load corresponding to 15% of
the maximum. Load and sets were progressively increased to
three sets of 12 repetitions at a load corresponding to 30% of
the maximum. Between sets, a rest period of ∼2–3 min was
allowed. At the end of each training session, a 5-min cool-down
was further allowed. Adherence to the protocol was considered
satisfactory if patients attended at least 80% of the total training
sessions.
Control MS group (MSCTL group), comprising 12 MS
patients (5 women and 7 men). The MSCT group patients were
not involved in any training program and continued their normal
lifestyle.
The study protocol conforms to the declaration of Helsinki
and was approved by the local ethical committee (Comitato
Etico dell’aziendaOspedaliero-Universitaria di Cagliari, approval
number 180 of the October 17th, 2012). Written informed
consent was obtained from all participants.
Experimental Design
Each patient was followed for 6 months and reported to our Lab
3 times: at the beginning of the study (T0), and at the 3rd and
6th month after T0 (T3 and T6, respectively). On each occasion,
they underwent the following study protocol: a general medical
examination with ECG followed by an incremental exercise on
an electro-magnetically-braked cycle ergometer (CUSTO Med,
Ottobrunn, Germany) to assess their physical capacity. The test
consisted of a linear increase of workload (10 W/min), starting
at 10 W, at a pedaling frequency of 60 rpm, until exhaustion
which was taken as the point at which the subject experienced
muscle fatigue (i.e., was unable to maintain a pedaling rate of
at least 50 rpm). During the incremental test, subjects were
connected to a gas analyzer (Ultima CPX, MedGraphics, St.
Paul, MN) to perform a CPT. Values of oxygen uptake (VO2),
carbon dioxide production (VCO2), pulmonary ventilation (VE),
and heart rate (HR) were collected. Afterwards, data from the
CPT were analyzed to calculate individual anaerobic threshold
(AT), which was detected by using the V slope method. Briefly,
a computerized regression analysis of VO2 slopes vs. VCO2
plot during exercise was employed (Beaver et al., 1986). Values
VO2, VE, HR, and workload (W) at AT were gathered (VO2AT,
VEAT, HRAT, WAT). Maximum oxygen uptake (VO2max) was
calculated as the average VO2 during the final 30 s of the
exercise test. Achievement of VO2max was considered as the
attainment of at least two of the following criteria: (1) a
plateau in VO2 despite increasing workload (<80 mL min
−1);
(2) respiratory exchange ratio (RER) above 1.10; and 3) heart
rate ± 10 beats·min−1 of predicted maximum heart rate
(HR) calculated as 220-age (Howley et al., 1995). Moreover,
maximumVE (VEmax), HR (HRmax), and workload (Wmax) were
calculated.
After the CPT session (the interval was at least 3 days, range
3–7 days), each subject was randomly assigned to the following
protocol to study metaboreflex activity:
(A) post-exercise muscle ischemia session (PEMI session),
which encompassed 3 min of resting, followed by 3 min
of exercise consisting in rhythmic dynamic handgrip at 30
compressions/min at 30% of the maximum assessed as the
peak reached during five previous maximal compressions on a
hydraulic dynamometer (MAP 1.1, Kern, Balingen, Germany).
Exercise was followed by PEMI on the exercised arm. PEMI
was induced by rapidly (in<3 s) inflating an upper arm biceps
tourniquet to 50 mmHg above peak exercise systolic pressure.
The ischemia lasted 3 min. Three minutes of recovery were
further allowed after the cuff was deflated, for a total of 6 min
of recovery. This protocol has been shown to trap the muscle
metabolites in the exercising limb and to maintain stimulation
of the metaboreceptors (Crisafulli et al., 2007, 2011; Marongiu
et al., 2013). This protocol has been demonstrated to induce
substantial cardiovascular activation in terms of enhancement
in stroke volume (SV), SVR, cardiac contractility, and cardiac
pre-load (Crisafulli et al., 2007, 2008, 2011; Roberto et al., 2012;
Milia et al., 2015a).
(B) control exercise recovery session (CER session): the same
rest-exercise protocol used for PEMI was performed followed
by a control exercise recovery of 6 min without tourniquet
inflation. Sessions A and B were spaced by at least 1 day
(interval 1–5 days) and were spaced by the last exercise session
by at least 24 h.
All experiments were carried out in a temperature-controlled, air-
conditioned room (temperature set at 22◦C and relative humidity
50%). All experiments were conducted in the morning (between
10.00 and 12.00 A.M.). Patients were instructed to have breakfast
at least 2 h before coming to our laboratory and to avoid caffeine
and alcohol ingestion the day before sessions were scheduled.
During both the PEMI and the CER test, hemodynamics
was assessed by means of impedance cardiography (NCCOM 3,
BoMed Inc., Irvine, CA), which has already been used in similar
experimental settings (Crisafulli et al., 2007, 2008, 2013; Roberto
et al., 2012). The data acquisition method is described in detail in
our previous published papers (Crisafulli et al., 2007, 2008, 2013;
Roberto et al., 2012). Briefly, by using a digital chart recorder
(ADInstruments, PowerLab 8sp, Castle Hill, Australia) NCCOM
3-derived analog traces of ECG, thorax impedance (Z0), and
Z0 first derivative were recorded and stored. After, the Sramek-
Bernstein equation (Bernstein, 1986) was applied to calculate
beat-to-beat SV from stored trans-thoracic impedance traces.
The pre-ejection period/left ejection time ratio (PEP/VET) was
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also calculated from impedance traces, as shown in previous
papers (Crisafulli et al., 2003, 2007, 2008). This ratio shows a
good correlation with the angiographic ejection fraction and
represents an inverse index of myocardial performance (Lewis
et al., 1977). Diastolic time (DT) was measured by subtracting
the sum of PEP and VET from the cardiac cycle total period
and, by dividing SV by DT, the ventricular filling rate (VFR) was
obtained (Marongiu et al., 2013). VFR is a measure of the mean
rate of diastolic blood flux. HRwas considered as the reciprocal of
the electrocardiogram R-R interval and cardiac output (CO) was
obtained by multiplying SV•HR. Subjects were also connected
to a manual sphygmomanometer for systolic (SBP) and diastolic
(DBP) blood pressure assessment, which was measured in the
non-exercised arm by the same physician throughout all protocol
sessions. To calculate MBP, the formula previously described by
Moran et al. (1995) which assesses MBP by taking into account
changes in the diastolic and systolic periods was used. SVR was
obtained by multiplying the MBP/CO ratio by 80, where 80
is a conversion factor to change units to standard resistance
units.
Data Analysis and Calculation
Descriptive statistics were performed on each variable to confirm
the assumptions of normality by means of the Kolmogorov-
Smirnov test. The alpha level was set at p < 0.05. Differences
between groups in means ± standard deviation (SD) of
anthropometric characteristics, CPT and hemodynamic variables
at T0 were carried out by unpaired t-test. Differences between
groups in means ± SD of variation from T0 in CPT parameters
reached by subjects at T3 and T6 were assessed by means of two-
way analysis of variance (ANOVA) for repeated measures for
the effects of group and time followed by Tukey post-hoc when
appropriate.
Hemodynamic responses during PEMI and CER tests were
averaged over 1 min. For each variable, the values at the third
minute of recovery from the tests (when a steady state was
expected to be reached) were taken into account. To assess
metaboreflex activity, the following procedure was employed:
for each parameter, the difference between the PEMI and
the CER test was calculated. This procedure allowed us to
assess metaboreflex response, i.e., the response due to the
metaboreflex activity (Milia et al., 2015a,b; Crisafulli et al.,
2013). Differences between groups in mean ± SD of measured
variables due to metaboreflex response were assessed by means
of two way ANOVA for repeated measures (factors: group and
time) followed by Tukey post-hoc when appropriate. Statistical
analysis was carried out utilizing commercially available software
(GraphPad Prism, La Jolla, CA). Statistical significance was
established as a p< 0.05 in all cases.
RESULTS
Four of the 25 patients (two from the MSIT and two from
the MSCTL group, one male and one female for each group)
abandoned the study. In detail, three of them had a clinical
deterioration which caused a substantial increment in the EDSS
scale, while one had a car accident which caused immobilization
for 3months. Thus, data shown are from 11MSIT patients and 10
MSCTL patients. Their physical characteristics, respectively, for
MSIT and MSCTL were: age 47.8 ± 10.8 and 40.7 ± 14 years (p
= 0.20), body mass 68.5 ± 17.6 kg and 64.5± 10.1 kg (p= 0.50),
height 168.4 ± 8 cm and 166 ± 9.2 cm (p = 0.53). There was
no difference in any parameters between groups. Table 1 shows
data from the CPT-test collected at T0. Data of VO2 are expressed
indexed by body weight. No statistical differences were observed
between groups. Table 2 reports mean values of hemodynamic
parameters recorded during rest periods preceding the PEMI and
the CER tests at T0, T3, and T6, respectively. Statistics did not
evidence any difference due to group or condition. Table 3 shows
hemodynamic data collected at the third minute of recovery of
the PEMI and the (CER) tests. Responses in parameters are also
shown.
Figure 1 depicts the variation with respect to T0 in CPT
parameters collected at T3 and T6. All variables were significantly
affected by group assignment, as in the MSIT group all variables
gathered at anaerobic threshold and at maximum workload
showed a significant main effect due to group.
Figures 2–4 report hemodynamic responses obtained during
the periods of metaboreflex activation, i.e., the difference between
the variable’s levels at the thirdminute of recovery from the PEMI
test minus the level at the third minute of recovery from the CER
test. None of the parameters were affected by group or time at T0,
T3, and T6. Notably, the SVR response was always positive (i.e.,
vascular resistance increased during the PEMI in comparison to
the CER test) with the exception of the MSIT group at T6, when
SVR actually decreased. However, statistical significance was not
reached.
DISCUSSION
This investigation aimed to ascertain whether the hemodynamic
response to metaboreflex activation was positively changed
by a period of adapted physical activity. Our reasoning was
that physical deconditioning, along with its effect on physical
capacity, could counteract the vasoconstriction, and the increase
in SVR response shown by MS patients during the metaboreflex.
TABLE 1 | Data from the cardiopulmonary test gathered at T0 in the
control Multiple Sclerosis group (MSCTL, n = 10) and in the intervention
Multiple Sclerosis group (MSIT, n = 11) group.
MSCTL MSIT p-value
VO2AT (mL/kg·min
−1 ) 14.1± 5.6 13.3± 4.3 0.71
VEAT (L·min-1) 28.1± 10.5 25.4± 8.2 0.44
HRAT (bpm) 111.4± 25.2 111.4± 11.11 0.99
WAT 60± 24.9 57.3± 23.7 0.79
VO2max (mL/kg·min
−1 ) 22.2± 7.6 18.6± 7.7 0.29
VEmax (L·min
−1 ) 52.9± 2 49.5± 31.3 0.76
HRmax (bpm) 136.8± 24.1 136.5± 17.4 0.97
Wmax 99± 31.8 92.7± 36.6 0.68
Parameters were collected at anaerobic threshold and at maximum exercise. Values are
mean ± SD.
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TABLE 2 | Hemodynamic data values during rest periods preceding post-exercise muscle ischemia (PEMI) and control exercise recovery (CER) tests at
T0, T3, and T6 in both control Multiple Sclerosis group (MSCTL, n = 10) and in the intervention Multiple Sclerosis group (MSIT, n = 11) group.
MSCTL (T0) MSIT (T0) p-value (group
and condition
effect)
MSCTL (T3) MSIT (T3) p-value (group
and condition
effect)
MSCTL (T6) MSIT (T6) p-value (group
and condition
effect)
HR (bpm)
Rest before PEMI 71.1±12.7 72.4±8.1 0.94 70.0± 10.1 70.4± 11.5 0.78 76.9± 14.8 73.3± 9.5 0.43
Rest before CER 72.7±12.7 71.8±9.3 0.88 69.2± 8.8 70.6± 11.6 0.92 73.1± 12.8 70.7± 12.3 0.40
SV (ml)
Rest before PEMI 68.8±12.1 59.5±16.7 0.17 61.3± 17.6 62.2± 19.3 0.81 57.8± 16.6 60.0± 16.6 0.80
Rest before CER 63.4±15.7 59.9±14.6 0.57 59.2± 15.8 61.0± 21.2 0.78 60.8± 15.2 61.3± 21.4 0.69
CO (l·min−1)
Rest before PEMI 4.9±0.9 4.3±1.3 0.35 4.2± 0.9 4.2± 0.9 0.78 4.3± 1.2 4.4± 0.9 0.65
Rest before CER 4.4±1.2 4.3±1.4 0.53 4.2± 1.0 4.1± 0.9 0.67 4.3± 1.1 4.5± 1.1 0.88
PEP/VET
Rest before PEMI 0.5±0.2 0.6±0.1 0.78 0.52± 0.1 0.50± 0.1 0.29 0.53± 0.1 0.57± 0.2 0.65
Rest before CER 0.6±0.2 0.6±0.1 0.80 0.55± 0.1 0.51± 0.1 0.64 0.55± 0.2 0.56± 0.2 0.92
MBP (mmHg)
Rest before PEMI 92.2±12.9 89.4±11 0.63 89.5± 11.3 93.4± 9.2 0.10 85.1± 12.3 87.7± 10.4 0.18
Rest before CER 92.6±14.8 92±9 0.68 88.4± 13.5 95.1± 7.2 0.92 84.6± 10.4 91.6± 12.9 0.63
SVR (dyne·s·cm−5)
Rest before PEMI 1545.9±418.5 1863.1±838.8 0.33 1827.0± 637.8 1864.3± 540.8 0.96 1686.9± 553.8 1445.2± 242.5 0.13
Rest before CER 1789±661 1891.6±776.7 0.53 1878.9± 691.5 1859.7± 488.3 0.90 1693.0± 675.2 1494.0± 307.3 0.85
VFR (ml·s−1)
Rest before PEMI 164.1±54 140.9±52.5 0.36 122.3± 29.9 115.5± 28.4 0.54 133.6± 51.7 154.6± 36.6 0.12
Rest before CER 151.2±70.4 140.8±58.9 0.72 117.5± 27.2 113.8± 26.2 0.70 131.7± 48.7 154.9± 42.7 0.95
HR, heart rate; SV, stroke volume; CO, cardiac output; PEP/VET, pre-ejection period/ventricular ejection time ratio; MBP, mean blood pressure; SVR, systemic vascular resistance; VFR,
ventricular filling rate. Values are mean ± SD.
TABLE 3 | Hemodynamic data at the third minute of recovery of post-exercise muscle ischemia (PEMI) and control exercise recovery (CER) tests at T0,
T3, and T6 in both control Multiple Sclerosis group (MSCTL, n = 10) and in the intervention Multiple Sclerosis group (MSIT, n = 11) group.
MSCTL (T0) MSIT (T0) MSCTL (T3) MSIT (T3) MSCTL (T6) MSIT (T6)
HR (bpm) 72.2± 13.2 73.4±10.6 69.5± 10.7 70.4±11.0 72.4± 12.3 73.1±10.4
PEMI 71.6± 11.5 71.9±9.5 69.2± 9.7 72.7±13.4 71.5± 11.4 69.9±11.5
CER 1 = 0.5± 3.8 1 = 1.4±2.6 1 = 0.2± 3.6 1 = 2.2±6.0 1 = 0.9± 5.1 1 = 3.1±5.3
SV (ml) 67.4± 16.7 57.1±16.0 60.9± 15.5 57.5±15.9 61.2± 13.2 73.1±15.1
PEMI 67.4± 20.3 58.8±14.5 60.5± 15.6 60.0±15.1 60.5± 14.5 71.4±14.7
CER 1 = 0.01± 6.3 1 = −1.6±3.2 1 = 0.4± 4.1 1 = −2.4±4.2 1 = 0.5± 4.7 1 = 0.6±2.3
CO (l·min-1) 4.8± 1.3 4.1±1.4 4.2± 1.1 4.1±1.0 4.4± 1.1 5.1±1.2
PEMI 4.7± 1.5 4.2±1.2 4.1± 0.9 4.2±0.7 4.3± 0.9 4.9±1.0
CER 1 = 0.1± 0.6 1 = 0.03±0.5 1 = 0.04± 0.5 1 = −0.02±0.7 1 = 0.07± 0.4 1 = 2.4±0.4
PEP/VET 0.5± 0.1 0.5±0.1 0.5± 0.1 0.4±0.1 0.4± 0.1 0.4±0.1
PEMI 0.5± 0.1 0.5±0.1 0.5± 0.09 0.4±0.09 0.4± 0.09 0.4±0.09
CER 1 = −0.03± 0.04 1 = 0.008±0.06 1 = 0.01± 0.05 1 = −0.01±0.04 1 = −0.01± 0.05 1 = 0.01±0.06
MBP (mmHg) 100.7± 16.9 100.0±9.2 96.2± 6.7 97.2±11.4 92.8± 7.1 94.5±6.3
PEMI 95.6± 16.7 89.6±9.6 89.4± 6.7 91.8±9.2 85.0± 5.2 90.3±5.5
CER 1 = 5.1± 6.0 1 = 10.3±6.3 1 = 6.7± 6.7 1 = 5.4±6.7 1 = 7.8± 4.0 1 = 4.2±11.0
SVR (dyne·s·cm-5) 1788.7± 626.7 1908.2±805.7 1814.1± 637.9 1857.5±535.0 1812.8± 535.0 1544.0±645.1
PEMI 1748.7± 686.1 1694.4±786.5 1710.2± 695.0 1734.6±428.5 1733.0± 495.3 1562.3±545.2
CER 1 = 40.0± 227.3 1 = 213.8±205.5 1 = 103.9± 166.9 1 = 158.8±369.1 1 = 79.7± 207.5 1 = −18.2±283.4
VFR (ml·s-1) 167.9± 79.2 131.2±64.2 107.0± 51.2 115.2±33.5 138.4± 36.2 159.9±24.4
PEMI 164.4± 79.3 125.5±44.3 111.6± 32.3 112.9±22.9 127.5± 35.4 147.7±22.2
CER 1 = 3.4± 29.4 1 = 5.7±32.2 1 = 4.5± 22.3 1 = 2.2±22.1 1 = 10.4± 18.4 1 = 12.2±24.4
Parameters response (∆) are also expressed. HR, heart rate; SV, stroke volume; CO, cardiac output; PEP/VET, pre-ejection period/ventricular ejection time ratio; MBP, mean blood
pressure; SVR, systemic vascular resistance; VFR, ventricular filling rate. Values are mean ± SD. See figures for results of statistics.
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FIGURE 1 | Variation with respect to T0 in CPT parameters collected at T3 and T6. Brackets denote a significant group effect, *p < 0.05 between groups.
Values are mean ± SD.
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FIGURE 2 | Responses due to metaboreflex activation in HR (A), SV (B),
and CO (C) at T0, T3, and T6, respectively. Groups are the MSCTL (n = 10)
and the MSIT (n = 11). Values are mean ± SD.
In a recent investigation conducted in our laboratory to discover
whether MS patients had a normal hemodynamic response to
the metaboreflex, it was found that these patients exaggeratedly
increased SVR. It was speculated that this phenomenon was the
consequence of the inactive lifestyle of these patients because of
their disease (Marongiu et al., 2015). Thus, an intervention able
to increase physical capacity may hypothetically counteract this
tendency to excessively vasoconstrict the arteriolar bed.
However, results of the present investigation contradict
this hypothesis. Indeed, notwithstanding MSIT group patients
FIGURE 3 | Responses due to metaboreflex activation in VFR (A) and
PEP/VET (B) at T0, T3, and T6, respectively. Groups are the MSCTL (n = 10)
and the MSIT (n = 11). Values are mean ± SD.
successfully increased their parameters related to physical
capacity as compared to the MSCTL group, this phenomenon
was not paralleled by any variation in the hemodynamic response
to the metaboreflex. Actually, SVR was unaffected by the training
program and no significant variations were detected in neither
SV nor CO response in both groups in study.
Our data are in accordance with the concept that a physical
intervention is able to improve exercise capacity in MS patients
(Ponichtera-Mulcare, 1993; Petajan and White, 1999; Rampello
et al., 2007; Dalgas et al., 2008; Andreasen et al., 2011). In reality,
the MSIT group substantially increased all CPT parameters
related to physical capacity after the period of training in
comparison with the MSCTL group, as testified by HR, W, VO2,
and VE gathered at both AT and maximum workload.
No significant variation in the Expanded Disability Status
scale score, neither in the MSCTL nor in the MSIT group was
observed. Therefore, the significant improvement in exercise
capacity found in the present study was very likely the result
of the physical intervention and the reduced sedentary lifestyle.
This occurrence confirms the hypothesis that an active lifestyle
is a useful behavior to counteract the negative consequences of
MS in terms of physical capacity, fatigue perception and physical
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FIGURE 4 | Responses due to metaboreflex activation in MBP (A) and
SVR (B) at T0, T3, and T6, respectively. Groups are the MSCTL (n = 10) and
the MSIT (n = 11). Values are mean ± SD.
fitness (Dalgas et al., 2008; Andreasen et al., 2011). Moreover, this
finding supports the concept that a sedentary lifestyle is harmful
in MS and that sedentary habits worsen the outcome in terms
of physical capacity and of the possibility to perform daily-life
activities.
Despite the fact that the physical intervention positively
affected the physical capacity of patients of the MSIT group, it
was unable to significantly change their hemodynamic response
during the metaboreflex in comparison with the MSCTL group.
Actually, the hemodynamic adjustment during the metaboreflex
remained similar between the two groups in study and no
significant difference was detected between them, although it
should be pointed out that there was a wide inter-subject
variability, as testified by the large parameters SD. A study with a
larger sample size would be useful to ascertain whether reducing
variability would result in a different outcome. Furthermore,
the physical intervention could not reverse the tendency to
increase SVR to reach the target blood pressure during the
metaboreflex, with the exception of the MSIT at T6, when the
response in this parameter was on average negative. The SVR
response found in the present investigation was very similar to
that reported in a recent study conducted in our Laboratory in
43 patients with MS (Marongiu et al., 2015). In detail, it was
reported that patients withMS on average increased SVR by 137.6
± 300.5 dyne·s−1·cm−5 whereas the mean response of healthy
controls was −14.3 ± 240.6 dyne·s−1·cm−5, thereby indicating
the absence of vasoconstriction in healthiness. It should however
be noticed that, notwithstanding the study by Marongiu et al.
(2015) was conducted in a numerous sample (43 patients), a large
SD was detected, which suggests that there is a wide inter-subject
variability in the SVR response in MS patients.
The fact that the cardiovascular response during the
metaboreflex activation was not improved notwithstanding the
enhanced exercise capacity suggests that the hemodynamics
during the metaboreflex was not related to exertional fatigue
in MS patients. It has been hypothesized that the discharges
of afferent group III and IV nerve endings in the muscle,
which are responsible for the metaboreflex eliciting, are at
least in part also responsible for the sensation of fatigue.
Feedback from these nervous afferents potentially inhibits central
motor drive and facilitates central fatigue, thereby limiting
exercise performance (Amann et al., 2008; Mulliri et al., 2016).
Thus, fatigue may be hypothetically related to the level of
metaboreflex activation. Since in the present investigation we
did not find any different hemodynamics before and after
the period of training, it is conceivable that the level of
metaboreflex activity was similar in these two conditions.
However, exercise capacity was higher after training, thereby
indicating that probably deconditioning is more important than
cardiovascular dys-regulation in the genesis of fatigue in MS
patients.
The hemodynamic scenario depicted in the present study
resembled the typical response observed in several diseases such
as heart failure, obesity, metabolic syndrome, and hypertension,
where an excessive sympathetic tone has often been reported
(Crisafulli et al., 2007; Delaney et al., 2010; Milia et al., 2015b),
whereas in normal subjects vasoconstriction is limited and the
target blood pressure is reached mainly by a cardiac output-
mediated mechanism (Crisafulli et al., 2003).
It was hypothesized that alterations in skeletal muscle
morphology, metabolism, blood flow, and function due to
physical deconditioning are important determinants in the
altered hemodynamic response to exercise and metaboreflex
activation in patients with heart failure. This is known as
“the muscle hypothesis” of heart failure (Piepoli and Crisafulli,
2014). Of note, in these patients it appears that physical
training can partially reverse this condition (Piepoli et al., 2006),
since improving exercise capacity is accompanied by a gradual
reduction in metaboreflex-induced vasoconstriction (Piepoli
and Crisafulli, 2014). One possible mechanism is that exercise
can improve muscle aerobic metabolism, thereby reducing
anaerobic end-products accumulation, which are responsible for
metaboreflex activation. Moreover, training can counteract the
effect of sedentary lifestyle, which induces a shift from type I to
type II in muscle fibers composition. It is well known that type
II fibers produce a larger amount of metabolic by-products than
type I, and in turn this fact can cause an increase in metaboreflex
activity with altered hemodynamic response (Piepoli et al., 2008).
It is then conceivable that our cohorts of MS patients showed
an altered hemodynamic response to the metaboreflex because
of a chronic muscle disuse. Actually, it has been reported a
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shift in fiber type composition from type I fibers to a greater
proportion of type II fibers in MS patients as a consequence of
deconditioning (Dalgas et al., 2008).
It is however a matter of fact that in the present study there
was the lack of any significant improvement in the hemodynamic
response to the metaboreflex, although future research with
more patients is warranted. It should be kept in mind that MS
is a demyelinating disease, where the progression of nervous
fibers degeneration is unpredictable and does not depend on
patients’ physical capacity. Hence, it is possible that the lack
of improvement in the hemodynamic response during the
metaboreflex could simply depend on irreversible damages at the
level of central nervous system. For instance, lesions at the level
of the spinal cord, especially at the dorsal horn, where there are
important sensory inputs for the metaboreflex, could account for
the altered hemodynamics that these patients showed after the
period of training.
Limitations of the Study
One limitation of the present study is the reduced number of
patients enrolled that could potentially have masked the effect
of the training intervention on the cardiovascular regulation.
While the sample size did suffice to discover positive effects
on CPT parameters due to training, it was probably not large
enough to identify effects on hemodynamic variables in response
to the metaboreflex. Thus, it is possible to speculate that the
lack of significant reduction in the SVR response was the
result of the small sample size of the present investigation. It
can be hypothesized that increasing the number of subjects
enrolled would have resulted in a significant reduction in the
SVR response. Further research is warranted on this topic to
better clarify this point. Another limitation is that it is possible
that the period of intervention, i.e., 6 months, was too short
to successfully affect the cardiovascular regulation. It can be
speculated that a longer period of intervention (i.e., 12 months)
would have led to amore pronounced reduction in SVR response.
In a similar experimental setting conducted in heart transplant
recipients, where a 12-month period of observation was applied
after transplant, the maximum reduction in SVR response was
obtained after 12 months (Crisafulli et al., 2013). In the quoted
study, it was concluded that, despite improved cardiac function,
the impairment in the cardiovascular regulation in response to
muscle metaboreflex after heart transplant was evident only after
several months. That is, it takes months to re-set cardiovascular
regulation after a long period of sedentary habits. Since our
MS patients had sedentary habits, it can be speculated that
they needed a longer period of training to completely reverse
the consequence of sedentary a lifestyle due to their pathology.
A final limitation is that we did not take into consideration
parameters related to quality of life in the MS patients. Instead,
only variables related to exercise capacity and cardiovascular
regulation were considered. Therefore, the present data do
not allow to discover whether or not exercise capacity and/or
cardiovascular regulation contribute to quality of life in these
patients.
In conclusion, results of the present study demonstrate
that a 6-month period of adapted physical training improved
physical capacity and cardiopulmonary indexes related to it in
patients suffering frommultiple sclerosis. However, it was unable
to counteract the tendency of these patients to vasoconstrict
the arteriolar bed to achieve the target blood pressure in
response to the muscle metaboreflex. Increasing the sample
size and the period of intervention is mandatory to better
understand whether a more positive outcome could be achieved
by physical training. Further research is needed to confirm this
hypothesis.
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